OUTLOOK THERAPEUTICS
Price & Volume
Stats
See more52W Range | $0.79-$3.39 |
Market Cap | $79.5M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $1.5M |
Revenue Growth (YoY) | 658.3% |
Gross Profit (12 Mos) | -$40.3M |
Diluted EPS | -$0.84 |
News
See moreYahoo Finance • 5 days ago
Outlook Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
Yahoo Finance • 16 days ago
Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
Yahoo Finance • 26 days ago
Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
Yahoo Finance • 2 months ago
Outlook Therapeutics Provides Update on Type A Meeting with FDA
About
CEO | Mr. Robert Charles Jahr |
CFO | Mr. Lawrence A. Kenyon CPA |
Address | 111 S. Wood Avenue, Iselin, NJ, United States, 08830 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
